This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,355.70 delivery order contract is for the supply of RINVOQ ER 15 MG TABLET, a pharmaceutical product.
The contract has a firm fixed price pricing type and an ultimate completion date of November 21, 2024. It is not designated as a set-aside contract, indicating open competition.
Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
The DLA is the primary contracting agency, supporting the healthcare needs of military personnel, veterans, and other federal beneficiaries through efficient procurement of essential pharmaceutical and medical supplies.
Generated 2/19/25, 9:26 AM